物產中大(600704.SH):子公司擬斥3.28億參與金輪股份定增 進一步鞏固控股股東地位
格隆匯5月18日丨物產中大(600704.SH)公佈,2022年5月17日,金輪股份(002722.SZ)披露《2022年度非公開發行A股股票預案》,公司子公司物產中大元通實業集團有限公司(簡稱“元通實業”)和物產中大(浙江)產業投資有限公司(簡稱“產投公司”)擬參與認購金輪股份非公開發行的A股股票,認購金額約為人民幣3.28億元。
公司表示,子公司元通實業及產投公司通過參與認購金輪股份非公開發行A股股票,將進一步鞏固控股股東地位,同時對未來產業協同發展和業務佈局具有重要意義。該次認購符合公司整體戰略發展方向,有利於提升公司綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.